Fulgent Genetics Has Further Upside 

  • We think that after some consolidation of recent strong gains, shares of Fulgent Genetics have further upside.
  • The market for genetic testing is still in the early innings, and the company has established itself as a genuine supplier.
  • The company is on the verge of becoming profitable, and the shares are still not that expensive, despite an 80%+ rise this year.

Source: Fulgent Genetics Has Further Upside – Fulgent Genetics, Inc. (NASDAQ:FLGT) | Seeking Alpha